Form 8-K - Current report:
SEC Accession No. 0001104659-24-086991
Filing Date
2024-08-08
Accepted
2024-08-08 07:05:39
Documents
14
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421124d1_8k.htm   iXBRL 8-K 27121
2 EXHIBIT 99.1 tm2421124d1_ex99-1.htm EX-99.1 96881
  Complete submission text file 0001104659-24-086991.txt   312211

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA trvn-20240808.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvn-20240808_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvn-20240808_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2421124d1_8k_htm.xml XML 3675
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36193 | Film No.: 241185977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)